Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -22.00 -0.2% 11,178.00 11,176.00 11,180.00 11,230.00 11,074.00 11,168.00 1,330,367 16:29:55
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 27,668.9 -196.0 5.9 1,718.6 173,160

Astrazeneca Share Discussion Threads

Showing 5526 to 5542 of 5825 messages
Chat Pages: 233  232  231  230  229  228  227  226  225  224  223  222  Older
DateSubjectAuthorDiscuss
15/1/2022
02:20
Anyone seen this ??? see the thread

South Shields vax bus served papers and shut down

Scroll down to see

UK police launch major investigation into MNRA vax related corporate crimes and threats to public health (including murder and genocide)

https://twitter.com/DonnyDa87811656/status/1482083004428267525

jimarilo
15/1/2022
02:19
National Emergency ........The truth is out !!

https://twitter.com/CharlotteEmmaUK/status/1481956734495252484


DR. SAM WHITE.. IMPORTANT INFORMATION THIS HAS TO BE SHARED

https://brandnewtube.com/watch/dr-sam-white-important-information-this-has-to-be-shared_5KL8mCLn8YTMx5L.html

jimarilo
14/1/2022
20:36
Unfortunately yes. I struggle to understand what's going on. It's like everyone that hasn't had the vaccine has gone mad. (Light fuse, stand back and enjoy the show!) ?
mattboxy
14/1/2022
18:26
‘You never ever mass vaccinate during a pandemic’

Aiden, which other pandemics on the same scale are you referring to?

Surely influenza is the only nearest equivalent and the vulnerable are offered a vaccine (that is tweaked for the most likely strain that year - so also an ‘experimental drug’, like all others) each year?

woodyjmw
12/1/2022
14:36
Are ALL ADVFN threads now being overrun with nutters and wackjobs?
pvb
11/1/2022
17:50
hTTps://brandnewtube.com/watch/military-historian-exposes-covid-psyops_qmFjmDcRrKM1AJv.html
aidenabettin
11/1/2022
17:38
You never ever mass vaccinate during a pandemic
.
I'm a nutter for calling for a halt to vaccination and especially the pfizer/moderna mRNA gene therapy booster
.
The WHO now agrees
.
Who is crazy?

aidenabettin
11/1/2022
17:28
hTTps://www.dailysabah.com/life/science/repeated-covid-19-boosters-not-viable-new-vaccines-key-who.Translation.Although many are dying from the vaccines new vaccines will be required to increase the death rate as laid out in the Eugenics plan
aidenabettin
11/1/2022
17:21
No keep talking aids a bettin and (show me the way) to jimarilo, your diatribe has just raised the price by 142p today ! Great reading, need a good laugh now and again.
peterev4
11/1/2022
10:49
Ffs give us a break
riskonricky
11/1/2022
10:18
My new accommodation being set up. hTTps://brandnewtube.com/watch/u-s-tyrants-push-covid-internment-camps_fARlKB5FBecgVTM.html
aidenabettin
11/1/2022
10:03
Thought you'd fu-coughed already aiden. So bored or you guys trolling
riskonricky
11/1/2022
09:59
Many are now refusing experimental boosters drugs and vaccines.Vaccine related deaths will become the #1 cause of death over the next year Imo
aidenabettin
10/1/2022
12:40
"First UKHSA Vaccine Surveillance Report of 2022.

Last 4 weeks of 2021:

65% of adult "Covid hospitalisations" were vaccinated.

72% of "Covid deaths" were vaccinated.

Anyone, and I mean anyone, who says the vast majority are unjabbed is lying to you."

Https://twitter.com/gazcon/status/1479930065588785161

jimarilo
10/1/2022
09:45
And now, albeit a little late some news on AZN.

Exclusive Speaker Interview with Karen Capper, AstraZeneca Ahead of the Pharmaceutical Microbiology UK Virtual Conference
01/08/2022 | 08:01am GMT

SMi Group reports: exclusive speaker interview with microbiology expert Karen Capper, AstraZeneca about the developments in the microbiology field.

London, United Kingdom January 08, 2022 --(PR.com)-- Now in its 10th Annual year, the Pharmaceutical Microbiology UK conference is taking place on 17th and 18th January 2022 as a virtual conference with online access only.

The conference will bring together industry experts to discuss and analyse the latest advancements and challenges within pharmaceutical microbiology.

Interested parties can register for the conference and the two interactive workshops at hxxp://www.pharma-microbiology.com/PR5

Ahead of the virtual conference taking place in less than two weeks, SMi Group caught up with Karen Capper, Associate Director - Head of Microbiology, Pharmaceutical Development, AstraZeneca. Below is the excerpts of the interview:

SMi Group - The industry surrounding pharmaceutical microbiology is maturing each year, in your opinion, what are some of the most major developments that have taken place in the last year?
Karen Capper, "The need to act quickly through the pandemic has enabled more acceptance of rapid methods and new technology in microbiology. The microbiologists need to ensure this momentum is maintained and the industry continues to use some of this technology for pharmaceutical products."

SMi Group - What topic will you be presenting on at the conference, and what would you say makes it especially important in 2022?
Karen Capper - "I will be presenting on the use of Virtual Technology for Microbiology and Aseptic training. The use of this type of technology enables a faster capability uplift of staff whilst reducing the burden on the facility and microbiology laboratories. The increase in the need for aseptic and microbiology staff through the pandemic has made this a very useful tool for future training."

SMi Group What are your thoughts on the shifting regulatory environment, and how is this currently impacting your role?
Karen Capper - "The main impacts I see in the regulatory environment is managing the various market requirements whilst running an efficient business. The need to comply with more rest of the world markets has led to complexity in method development and acceptance."

To read the full interview visit the download centre on the conference website to read the full interview at hxxp://www.pharma-microbiology.com/PR5

Karen Capper will be presenting on day two of the Pharmaceutical Microbiology UK Virtual Conference along with Suzanne Nutter, QA Group Manager, AstraZeneca on: “Applying Virtual Reality To Training In Aseptic Processing & Microbiology" which will cover:

• Overview of the technology
• Rollout plan and approach
• Pros and cons of the technology for training

The conference is proudly sponsored by ECOLAB and Microgenetics

For media enquiries and press pass requests, contact Simi Sapal, Head of Marketing on +44 (0) 20 7827 6162 or ssapal@smi-online.co.uk.

SMi’s 10th Annual Pharmaceutical Microbiology Conference
Conference: 17 - 18 January 2022
Workshops: 19 January 2022
Virtual Conference: Online Access Only
hxxp://www.pharma-microbiology.com/PR5
#SMiPharmaMicroUK

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at hxxp://www.smi-online.co.uk.

Contact Information:
SMi Group
Simi Sapal
(0) 20 7827 6162
Contact via Email
hxxp://www.pharma-microbiology.com/PR5

Read the full story here: hxxps://www.pr.com/press-release/852542

Press Release Distributed by PR.com

Copyright © 2022 PR.com and its licensors , source US Press Releases

beckers2008
09/1/2022
15:46
No problem m8
riskonricky
09/1/2022
12:19
Bye bye scum bag
riskonricky
Chat Pages: 233  232  231  230  229  228  227  226  225  224  223  222  Older
Your Recent History
LSE
AZN
Astrazenec..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20221204 00:09:17